New mRNA shot targets wrinkles from within
Symptom relief
Not yet recruiting
This early-stage study tests whether a new mRNA injection called SPOT-mRNA01 is safe and tolerable in healthy adults. Ten volunteers will receive either the injection or a placebo to check for side effects and measure changes in skin collagen and thickness. The goal is to see if …
Phase: PHASE1 • Sponsor: SIPO Biotechnology Co. Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC